-
medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on noncoding RNAs and endothelial stress response. Her team integrates innovative high
-
motivated and talented individual to fill a postdoctoral position in the field of gamma-herpesvirus structural biology. The goal of the postdoctoral candidate will be to elucidate the mechanisms of gamma
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
(EVs), for groundbreaking minimally invasive diagnostics. Uncover disease-specific molecules within EVs using cell biology and super-resolution microscopy. Contribute to developing a revolutionary
-
). We are one of the few interventional oncology groups in the United States with a basic science lab, large animal tumor model, and several active clinical trials, which enables us to translate new
-
immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
focused on improving the health outcomes of childhood and adult-onset cancer patients. He is a Leukemia & Lymphoma Society Research Scholar and has been the recipient of several National Institutes
-
well as disease relapse in order to design novel inhibitors to intervene the malignancies; 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology. The group conducts
-
nurses to order protocol-related tests and evaluations. Identify and communicate protocol and data management issues to supervisors and works on special projects as assigned. Maintain professional